These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 18391047)
21. Toxin B is essential for virulence of Clostridium difficile. Lyras D; O'Connor JR; Howarth PM; Sambol SP; Carter GP; Phumoonna T; Poon R; Adams V; Vedantam G; Johnson S; Gerding DN; Rood JI Nature; 2009 Apr; 458(7242):1176-9. PubMed ID: 19252482 [TBL] [Abstract][Full Text] [Related]
22. Development of a recombinant toxin fragment vaccine for Clostridium difficile infection. Karczewski J; Zorman J; Wang S; Miezeiewski M; Xie J; Soring K; Petrescu I; Rogers I; Thiriot DS; Cook JC; Chamberlin M; Xoconostle RF; Nahas DD; Joyce JG; Bodmer JL; Heinrichs JH; Secore S Vaccine; 2014 May; 32(24):2812-8. PubMed ID: 24662701 [TBL] [Abstract][Full Text] [Related]
23. A leaky human colon model reveals uncoupled apical/basal cytotoxicity in early Ok MT; Liu J; Bliton RJ; Hinesley CM; San Pedro EET; Breau KA; Gomez-Martinez I; Burclaff J; Magness ST Am J Physiol Gastrointest Liver Physiol; 2023 Apr; 324(4):G262-G280. PubMed ID: 36749911 [No Abstract] [Full Text] [Related]
24. Toxin-mediated paracellular transport of antitoxin antibodies facilitates protection against Clostridium difficile infection. Zhang Z; Chen X; Hernandez LD; Lipari P; Flattery A; Chen SC; Kramer S; Polishook JD; Racine F; Cape H; Kelly CP; Therien AG Infect Immun; 2015 Jan; 83(1):405-16. PubMed ID: 25385797 [TBL] [Abstract][Full Text] [Related]
25. Immunization with Bacillus spores expressing toxin A peptide repeats protects against infection with Clostridium difficile strains producing toxins A and B. Permpoonpattana P; Hong HA; Phetcharaburanin J; Huang JM; Cook J; Fairweather NF; Cutting SM Infect Immun; 2011 Jun; 79(6):2295-302. PubMed ID: 21482682 [TBL] [Abstract][Full Text] [Related]
26. Use of a neutralizing antibody helps identify structural features critical for binding of Kroh HK; Chandrasekaran R; Rosenthal K; Woods R; Jin X; Ohi MD; Nyborg AC; Rainey GJ; Warrener P; Spiller BW; Lacy DB J Biol Chem; 2017 Sep; 292(35):14401-14412. PubMed ID: 28705932 [No Abstract] [Full Text] [Related]
27. The xenobiotic sensing pregnane X receptor regulates tissue damage and inflammation triggered by C difficile toxins. Erickson SL; Alston L; Nieves K; Chang TKH; Mani S; Flannigan KL; Hirota SA FASEB J; 2020 Feb; 34(2):2198-2212. PubMed ID: 31907988 [TBL] [Abstract][Full Text] [Related]
28. The protective effect of recombinant Lactococcus lactis oral vaccine on a Clostridium difficile-infected animal model. Yang XQ; Zhao YG; Chen XQ; Jiang B; Sun DY BMC Gastroenterol; 2013 Jul; 13():117. PubMed ID: 23865596 [TBL] [Abstract][Full Text] [Related]
30. Identification of a novel virulence factor in Clostridium difficile that modulates toxin sensitivity of cultured epithelial cells. Miura M; Kato H; Matsushita O Infect Immun; 2011 Sep; 79(9):3810-20. PubMed ID: 21746858 [TBL] [Abstract][Full Text] [Related]
31. Binary toxin-producing, large clostridial toxin-negative Clostridium difficile strains are enterotoxic but do not cause disease in hamsters. Geric B; Carman RJ; Rupnik M; Genheimer CW; Sambol SP; Lyerly DM; Gerding DN; Johnson S J Infect Dis; 2006 Apr; 193(8):1143-50. PubMed ID: 16544255 [TBL] [Abstract][Full Text] [Related]
32. The role of toxin A and toxin B in Clostridium difficile infection. Kuehne SA; Cartman ST; Heap JT; Kelly ML; Cockayne A; Minton NP Nature; 2010 Oct; 467(7316):711-3. PubMed ID: 20844489 [TBL] [Abstract][Full Text] [Related]
33. A neutralizing antibody that blocks delivery of the enzymatic cargo of Kroh HK; Chandrasekaran R; Zhang Z; Rosenthal K; Woods R; Jin X; Nyborg AC; Rainey GJ; Warrener P; Melnyk RA; Spiller BW; Lacy DB J Biol Chem; 2018 Jan; 293(3):941-952. PubMed ID: 29180448 [No Abstract] [Full Text] [Related]
34. Antibody against TcdB, but not TcdA, prevents development of gastrointestinal and systemic Clostridium difficile disease. Steele J; Mukherjee J; Parry N; Tzipori S J Infect Dis; 2013 Jan; 207(2):323-30. PubMed ID: 23125448 [TBL] [Abstract][Full Text] [Related]
35. Immunisation of mares with binding domains of toxins A and B of Clostridium difficile elicits serum and colostral antibodies that block toxin binding. Artiushin S; Timoney JF; Fettinger M; Fallon L; Rathgeber R Equine Vet J; 2013 Jul; 45(4):476-80. PubMed ID: 23206274 [TBL] [Abstract][Full Text] [Related]
36. Neutralization of Clostridium difficile toxin A with single-domain antibodies targeting the cell receptor binding domain. Hussack G; Arbabi-Ghahroudi M; van Faassen H; Songer JG; Ng KK; MacKenzie R; Tanha J J Biol Chem; 2011 Mar; 286(11):8961-76. PubMed ID: 21216961 [TBL] [Abstract][Full Text] [Related]
37. Prevalence and characterization of a binary toxin (actin-specific ADP-ribosyltransferase) from Clostridium difficile. Gonçalves C; Decré D; Barbut F; Burghoffer B; Petit JC J Clin Microbiol; 2004 May; 42(5):1933-9. PubMed ID: 15131151 [TBL] [Abstract][Full Text] [Related]
38. The cytotoxic effect of Clostridioides difficile pore-forming toxin CDTb. Landenberger M; Nieland J; Roeder M; Nørgaard K; Papatheodorou P; Ernst K; Barth H Biochim Biophys Acta Biomembr; 2021 Jun; 1863(6):183603. PubMed ID: 33689753 [TBL] [Abstract][Full Text] [Related]
39. A possible role for Clostridium difficile in the etiology of calf enteritis. Hammitt MC; Bueschel DM; Keel MK; Glock RD; Cuneo P; DeYoung DW; Reggiardo C; Trinh HT; Songer JG Vet Microbiol; 2008 Mar; 127(3-4):343-52. PubMed ID: 17964088 [TBL] [Abstract][Full Text] [Related]
40. Lectin Activity of the TcdA and TcdB Toxins of Clostridium difficile. Hartley-Tassell LE; Awad MM; Seib KL; Scarselli M; Savino S; Tiralongo J; Lyras D; Day CJ; Jennings MP Infect Immun; 2019 Mar; 87(3):. PubMed ID: 30530621 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]